Manipal Health Sets Final IPO Price, Allotment Unveiled | Investors Await Verdict
By ETF Desk
The Manipal Health Group has announced the final Good‑will Minimum Price (GMP) for its upcoming initial public offering, setting the per‑share valuation in a filing to be disclosed in August after a 45‑day due‑diligence period. The company stated that the IPO shares will be priced above the previously hinted range, with shares to be allotted through an online book building process over a 6‑day window.
Manipal Health, a subsidiary of the larger Manipal Global Health Group, operates a chain of tertiary care hospitals and specialty clinics across Karnataka, including Udupi district. Analysts project the company’s net profit for FY 2026 to reach approximately ₹?? crores, driven by expanding outpatient services and a growing tele‑health platform. The IPO aims to raise ₹?? crores to finance infrastructure upgrades and regional expansion.
The market reaction to the GMP announcement has been cautious, with trading data showing a slight uptick in speculative buying. Investors are weighing the company's robust growth trajectory against sectoral headwinds such as rising operating costs. The proceeds from the IPO are expected to accelerate Manipal Health’s penetration into underserved districts, potentially creating new employment opportunities in Udupi’s emerging healthcare sector.